# Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study

Study · id `cardio:ct-nct01385319` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01385319](<https://clinicaltrials.gov/study/NCT01385319>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01385319

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 1606 participants.

## Technical summary

Registry record NCT01385319. Randomized; single masking; primary purpose treatment. Start 2011-06 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 1606 participants (enrolled count; ClinicalTrials.gov record NCT01385319, source copy `cardio:ctgov-nct01385319-2012-10-10`, retrieved 2026-10-26)
- Start date: 2011-06 (registry gives no type) (ClinicalTrials.gov record NCT01385319, source copy `cardio:ctgov-nct01385319-2012-10-10`, retrieved 2026-10-26)
- Primary completion: 2012-09 (actual) (ClinicalTrials.gov record NCT01385319, source copy `cardio:ctgov-nct01385319-2012-10-10`, retrieved 2026-10-26)
- Completion: 2017-12 (anticipated) (ClinicalTrials.gov record NCT01385319, source copy `cardio:ctgov-nct01385319-2012-10-10`, retrieved 2026-10-26)
- Countries: Hungary; Italy; Portugal; Switzerland (ClinicalTrials.gov record NCT01385319, source copy `cardio:ctgov-nct01385319-2012-10-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01385319-2012-10-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Zotarolimus-eluting Endeavor Sprint Stent in Uncertain DES Candidates (ZEUS) Study
- Acronym: ZEUS
- Condition: Coronary Artery Disease
- Intervention (Device): Bare metal stent implantation
- Intervention (Device): zotarolimus eluting stent
- Lead sponsor: Marco Valgimigli
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates (`cardio:pubmed-25720624`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Is Bare-Metal Stent Implantation Still Justifiable in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention?: A Pre-Specified Analysis From the ZEUS Trial (`cardio:pubmed-26965932`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: e8805a583e1299e9ab42e494e1c3cd39ffc697a2f21f1925545b3e90180129c7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
